A D.C. federal judge on Tuesday ordered the U.S. Food and Drug Administration to either perform an analysis of its memorandum that created new regulations to fully implement a decades-old rule governing pharmacy compounding, or certify that the memo won't greatly impact small businesses, like the pharmacies challenging the memo.